Current Studies
SHASTA STUDY
High Triglycerides
The Shasta Study is looking at how safe an investigational study drug is and whether it works for people with severe hypertriglyceridemia, also called SHTG. The study drug, called plozasiran will be compared with a placebo.
SHTG is a condition in which the level of triglycerides, or fats in the blood, are very high.
Enrollment ends soon! May 23, 2025
Remain 1
The Remain 1 Study is a clinical study exploring the first non-drug alternative for weight maintenance in obesity. This study evaluates a procedure called Revita®, which is like a upper GI endoscopy.
Enrollment is open
Revitalize 1
Researchers believe that the first section of your small intestine (the duodenum), located just after your stomach, has an important role in the development of type 2 diabetes. The duodenum is sensitive to the foods you eat and helps you maintain a health metabolism and blood glucose levels.
Enrollment is paused until Summer.
ABBVIE
Efficacy and safety of Armour Thyroid treatment in patients with primary hypothyroidism
The purpose of this study is to evaluate if Armour Thyroid is safe and effective in the treatment of hypothyroidism. This study will compare the effect of Armour Thyroid on hypothyroidism and its safety with synthetic drug T4 (Levothyroxine).
Enrollment is open
Contact us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!